Anzeige
Mehr »
Login
Mittwoch, 22.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D38R | ISIN: US0547548588 | Ticker-Symbol: AY20
Stuttgart
22.05.24
08:07 Uhr
2,840 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
AYTU BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
AYTU BIOPHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,8402,96012:30

Aktuelle News zur AYTU BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoEarnings call: Aytu BioPharma sees revenue growth, shifts focus to ADHD3
DoAytu Biopharma Inc reports results for the quarter ended in March - Earnings Summary1
15.05.Aytu BioScience up 5% as quarterly results beat on both lines1
15.05.Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results232Q3 2024 ADHD Portfolio net revenue up 49% compared to Q3 2023Q3 2024 adjusted EBITDA 1 improved by $7.0 million compared to Q3 2023TTM March 2024 operating income of $7.3 million for the Rx BusinessTTM...
► Artikel lesen
15.05.AYTU BIOPHARMA, INC - 8-K, Current Report-
14.05.Aytu BioScience Q3 Earnings Preview2
08.05.Aytu BioPharma, Inc.: Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024207DENVER, CO / ACCESSWIRE / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its financial...
► Artikel lesen
03.04.Aytu BioPharma, Inc.: Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024291Webcasted presentation to take place at 4:40 p.m. Eastern timeDENVER, CO / ACCESSWIRE / April 3, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused...
► Artikel lesen
15.02.Earnings call: Aytu BioPharma achieves first positive operating income4
14.02.Aytu BioScience GAAP EPS of -$0.04 beats by $0.21, revenue of $22.93M beats by $1.18M3
14.02.Aytu BioPharma, Inc.: Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter325Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted...
► Artikel lesen
14.02.AYTU BIOPHARMA, INC - 8-K, Current Report2
14.02.AYTU BIOPHARMA, INC - 10-Q, Quarterly Report2
13.02.Aytu BioScience Q2 Earnings Preview3
13.02.Earnings Preview: Aytu BioPharma3
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 34.157The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS00941Q2030 AIRNET...
► Artikel lesen
07.02.Aytu BioPharma, Inc.: Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024339DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its financial...
► Artikel lesen
23.01.Aytu BioPharma, Inc.: Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024245DENVER, CO / ACCESSWIRE / January 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that...
► Artikel lesen
30.11.23Aytu BioPharma, Inc.: Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023445Webcasted presentation to take place at 1:10pm ETDENVER, CO / ACCESSWIRE / November 30, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing...
► Artikel lesen
14.11.23Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results852Q1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in Q1 2024Q1 2024 ADHD net revenue up 31% compared to Q1 2023$20.0 million cash balance...
► Artikel lesen
Seite:  Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1